Efstathios Iliodromitis Selected Research

Efstathios Iliodromitis Research Topics

Disease

5	Heart Failure 10/2010 - 05/2004
4	COVID-19 08/2021 - 01/2020
3	ST Elevation Myocardial Infarction 10/2018 - 08/2017
2	Rheumatoid Arthritis 11/2020 - 10/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2018 - 01/2018
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2010 - 04/2009
2	Ischemia 10/2002 - 02/2002
1	Hyperglycemia 08/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2020
1	Disease Progression 01/2020
1	Clinical Deterioration 01/2020
1	Diarrhea 01/2020
1	Atherosclerosis 10/2019
1	Atrial Fibrillation 01/2018
1	Hemorrhage 01/2018
1	Obesity 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2017
1	Acute Coronary Syndrome 09/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2017
1	Infections 09/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2014
1	Cardiomyopathies (Cardiomyopathy) 06/2013
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 10/2010
1	Anemia 04/2009
1	Myocardial Infarction 10/2002
1	Infarction (Infarctions) 10/2002

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 08/2021 - 01/2020
2	tocilizumab (atlizumab)FDA Link 11/2020 - 10/2019
2	Liraglutide FDA Link 01/2020 - 01/2018
2	Colchicine FDA LinkGeneric 01/2020 - 01/2020
2	AnticoagulantsIBA 01/2018 - 08/2017
2	Digoxin (Digitek)FDA LinkGeneric 09/2014 - 01/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2010 - 03/2005
2	Simendan (Levosimendan)IBA 03/2005 - 05/2004
2	Interleukin-6 (Interleukin 6)IBA 03/2005 - 05/2004
2	AntioxidantsIBA 10/2002 - 02/2002
2	Malondialdehyde (Propanedial)IBA 10/2002 - 02/2002
1	EnzymesIBA 08/2021
1	AngiotensinsIBA 08/2021
1	LDL CholesterolIBA 12/2020
1	CholesterolIBA 12/2020
1	Biological ProductsIBA 11/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	InflammasomesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	empagliflozinIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	SodiumIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2019
1	Prednisolone (Predate)FDA LinkGeneric 10/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2019
1	TicagrelorIBA 10/2018
1	cangrelorIBA 10/2018
1	PCSK9 InhibitorsIBA 09/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	IncretinsIBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Purinergic P2Y Receptor AntagonistsIBA 01/2018
1	N(4)-oleylcytosine arabinosideIBA 01/2018
1	Vitamin K FDA Link 01/2018
1	Ustekinumab (CNTO 1275)FDA Link 09/2017
1	Etanercept (Enbrel)FDA Link 09/2017
1	LipidsIBA 09/2017
1	Interleukin-12 (IL 12)IBA 09/2017
1	InterleukinsIBA 09/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2017
1	HomocysteineIBA 09/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2017
1	factor V LeidenIBA 08/2017
1	Protein SIBA 08/2017
1	Protein CIBA 08/2017
1	Prothrombin (Factor II)IBA 08/2017
1	Factor V (Coagulation Factor V)IBA 08/2017
1	Antithrombin IIIIBA 08/2017
1	DiureticsIBA 09/2014
1	NitratesIBA 09/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2014
1	GadoliniumIBA 06/2013
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2010
1	Sertraline (Zoloft)FDA LinkGeneric 10/2010
1	Serotonin (5 Hydroxytryptamine)IBA 10/2010
1	Darbepoetin alfa (Aranesp)FDA Link 04/2009
1	Fas Ligand Protein (Fas Ligand)IBA 05/2004
1	CytokinesIBA 05/2004
1	3-((1H-1-indolyl)methyl) -4-amino 4,5-dihydro-1H,1,2,4 triazole-5-thioneIBA 10/2002
1	Free RadicalsIBA 10/2002
1	ChloridesIBA 10/2002
1	indoleIBA 10/2002

Therapy/Procedure

4	Therapeutics 09/2018 - 09/2014
2	Percutaneous Coronary Intervention 10/2018 - 01/2018